# US 2025/0082567 A1 · Facial cosmetic compositions and methods of improving facial aesthetics

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0082567 A1
- Document ID: US20250082567A1
- Status: Published application
- Kind: A1
- Application number: 18/957,081
- Filed: 2024-11-22
- Published: 2025-03-13
- Earliest claimed: 2022-01-27
- Assignees: Afore Oy
- Applicants: Aforé LLC
- Inventors: Julius Few; Alec Semersky
- Web page: https://patentgrep.com/patent/US20250082567A1

## CPC

- A61K 8/9789: Magnoliopsida [dicotyledons]
- A61K 8/347: {Phenols}
- A61K 8/498: {having 6-membered rings or their condensed derivatives, e.g. coumarin}
- A61K 8/64: Proteins; Peptides; Derivatives or degradation products thereof
- A61K 8/671: {Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal}
- A61K 8/735: {Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof}
- A61Q 19/08: Anti-ageing preparations
- A61K 2800/30: Characterized by the absence of a particular group of ingredients
- A61K 2800/91: Injection
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

Facial cosmetic compositions include a cannabinoid and a retinoid. The compositions can also comprise an aliphatic oligopeptide, an acetylated oligopeptide, and/or hyaluronic acid. Methods of administering facial cosmetic compositions include topically and/or subtopically administering to facial skin of a subject.

## Claims

### Claim at position 1

1-10. (canceled)

### Claim 11

A method of improving one or more facial aesthetics of a subject, comprising:
applying to facial skin of a subject a facial cosmetic composition comprises:
(a) a cannabinoid; and
(b) a retinoid,
wherein the composition is applied at least once per day for at least 21 days.

### Claim 12 (depends on 11)

The method of claim 11, wherein the composition is applied at least once per day for at least 42 days.

### Claim 13 (depends on 11)

The method of claim 11, wherein the composition is a cream applied to the facial skin without removal.

### Claim 14

A method of improving one or more facial aesthetics of a subject, the method comprising:
applying a facial cosmetic composition to facial skin of a subject, wherein the composition comprises:
(a) a cannabinoid; and
(b) a retinoid; and
treating the facial skin of the subject by a dermatological procedure before, during or after applying the facial cosmetic composition.

### Claim 15 (depends on 14)

The method of claim 14, wherein the composition further comprises one or more of (c) an aliphatic oligopeptide; (d) an acetylated oligopeptide; and (e) hyaluronic acid.

### Claim 16 (depends on 14)

The method of claim 14, wherein the facial skin treatment is selected from the group consisting of microdermabrasion, hydradermabrasion, dermabrasion, dermal planing, and combinations thereof.

### Claim 17 (depends on 14)

The method of claim 14, wherein the facial skin treatment comprises abrading a surface of facial skin of a subject to remove dead cells and/or cell debris from the skin surface;
wherein said abrading of the facial skin is performed before or during said applying the facial cosmetic composition to the facial skin.

### Claim 18 (depends on 17)

The method of claim 17, wherein said abrading is by microdermabrasion or by hydradermabrasion.

### Claim 19 (depends on 14)

The method of claim 14, wherein the facial cosmetic composition is applied to the facial skin by infusion.

### Claim 20 (depends on 14)

The method of claim 14, wherein the facial cosmetic composition is applied to the facial skin by injection or microinjection.

### Claim 21 (depends on 14)

The method of claim 14, wherein the facial cosmetic composition further comprises (c) an aliphatic oligopeptide, (d) an acetylated oligopeptide, and (e) hyaluronic acid.

### Claim 22 (depends on 11)

The method of claim 11, wherein the cannabinoid is selected from the group consisting of cannabidiol (CBD), precursors and derivatives of cannabidiol, and mixtures thereof.

### Claim 23 (depends on 11)

The method of claim 11, wherein the cannabinoid is selected from the group consisting of cannabidiol (CBD), Cannabidiolic Acid (CBDA), and mixtures thereof.

### Claim 24 (depends on 11)

The method of claim 11, wherein the retinoid is selected from the group consisting of retinol, retinal, retinyl esters, and mixtures thereof.

### Claim 25 (depends on 11)

The method of claim 11, further comprising (c) an aliphatic oligopeptide.

### Claim 26 (depends on 25)

The method of claim 25, wherein the aliphatic oligopeptide is a palmitoyl oligopeptide.

### Claim 27 (depends on 25)

The method of claim 25, wherein the aliphatic oligopeptide is present in the composition in an amount ranging from 0.5% by weight to 15% by weight.

### Claim 28 (depends on 11)

The method of claim 11, further comprising (d) an acetylated oligopeptide.

### Claim 29 (depends on 28)

The method of claim 28, wherein the acetylated oligopeptide is an acetyl hexapeptide.

### Claim 30 (depends on 28)

The method of claim 28, wherein the acetylated oligopeptide is present in the composition in an amount ranging from 0.5% by weight to 15% by weight.
